Who is the CEO of SNDX? | Glauxie AI

Q: Who is the CEO of SNDX?

Syndax Pharmaceuticals, Inc. (SNDX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Michael A. Metzger. Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical... Employees: 298.

Q: What does SNDX company do?

Learn what SNDX does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling SNDX?

Track recent insider buys and sells for SNDX with transaction details, amounts, and trends.

Q: What sector is SNDX in?

Find SNDX sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of SNDX?

🦉

Syndax Pharmaceuticals, Inc. (SNDX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMichael A. Metzger

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the...

Key Executives

Name	Title
Joseph Paul Eder	Member of Scientific Advisory Board & Chief Medical Officer
Keith Alan Goldan	CFO, Treasurer & Principal Accounting Officer
Kevin McManus	Chief People Officer
Luke J. Albrecht	Senior Vice President, General Counsel & Secretary
Michael A. Metzger	Chief Executive Officer & Director
Michael Downes	Co-Founder

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

SNDX Profile Financials

What does SNDX company do? Are insiders buying or selling SNDX? What sector is SNDX in?